Crossmark

Meta-analysis: The efficacy of metformin and other anti-hyperglycemic agents in prolonging the survival of hepatocellular carcinoma patients with type 2 diabetes

Crossref DOI link: https://doi.org/10.1016/j.aohep.2019.11.008

Published Print: 2020-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Zhou, Jian

Ke, Yang

Lei, Xuefen

Wu, Tiangen

Li, Yuehua

Bao, Tianhao

Tang, Haoran

Zhang, Cheng

Wu, Xuesong

Wang, Ge

Li, Jinze

Zhang, Heng

Ni, Fan

Ye, Zhengchen

Wang, Lin
Funding

Funding for this research was provided by:

National Natural Science Foundation of China
License Information

Text and Data Mining valid from 2020-05-01

Text and Data Mining valid from 2020-05-01

Version of Record valid from 2019-12-10
More Information

This article is maintained by: Elsevier

Article Title: Meta-analysis: The efficacy of metformin and other anti-hyperglycemic agents in prolonging the survival of hepatocellular carcinoma patients with type 2 diabetes

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2019.11.008

Content Type: article

Copyright: © 2019 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below